Literature DB >> 8546287

The influence of anaesthetic technique upon the immune response to hysterectomy. A comparison of propofol infusion and isoflurane.

C O Pirttikangas1, M Salo, M Mansikka, J Grönroos, K Pulkki, O Peltola.   

Abstract

Earlier studies on propofol have shown increased percentages of T helper cells after minor surgery. In this study, the effects of propofol infusion anaesthesia on the immune response were compared with those of combined isoflurane anaesthesia in 30 patients (median age 47 years, ASA 1-2) undergoing major surgery. The total dose of propofol in the propofol infusion group of 15 women was 860 mg (range 540-1520 mg) and the median end-expiratory isoflurane concentration in the combined isoflurane group of 15 women was 0.6% (range 0.5-0.8). The following were measured; leucocyte and differential counts; percentages of lymphocyte subpopulations (CD3, CD4, CD8, CD19, CD16 and HLA-DR+CD3); phytohaemagglutinin-, concanavalin A-, and pokeweed mitogen-induced and unstimulated lymphocyte proliferation; plasma interleukin-6; serum group II phospholipase A2, C-reactive protein and cortisol concentrations. Measurements were made pre-operatively, at the end of the operation and on the first and fifth postoperative days. No statistically significant overall differences were observed in the immune response between the groups. The serum cortisol response was weaker in the propofol group than in the isoflurane group (p < 0.05). Time-related changes were seen within the groups.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546287     DOI: 10.1111/j.1365-2044.1995.tb05951.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  Effects of propofol vs methohexital on neutrophil function and immune status in critically ill patients.

Authors:  Egbert Huettemann; Annabell Jung; Heinz Vogelsang; Nicole van Hout; Samir G Sakka
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

2.  Biological processes and pathway changes in isoflurane-induced anesthesia revealed by bioinformatics analysis of gene expression profiles.

Authors:  Hai Wang; Yi Jin; Jinyan Dai
Journal:  J Anesth       Date:  2015-07-30       Impact factor: 2.078

Review 3.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

4.  Perioperative cytokine release during coronary artery bypass grafting in patients of different ages.

Authors:  A Roth-Isigkeit; J Schwarzenberger; T v Borstel; H Gehring; E Ocklitz; K Wagner; P Schmucker; M Seyfarth
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 5.  Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.

Authors:  Takefumi Inada; Kozue Kubo; Koh Shingu
Journal:  J Anesth       Date:  2011-05-25       Impact factor: 2.078

6.  Plasma cytokine response to surgical stress in schizophrenic patients.

Authors:  A Kudoh; T Sakai; H Ishihara; A Matsuki
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

7.  Effects of epidural anesthesia and postoperative epidural analgesia on immune function in esophageal carcinoma patients undergoing thoracic surgery.

Authors:  Cheng-Yong Gu; Jin Zhang; Yan-Ning Qian; Qi-Feng Tang
Journal:  Mol Clin Oncol       Date:  2014-09-01

8.  A comparison of the immunological effects of propofol and isoflurane for maintenance of anesthesia in healthy dogs.

Authors:  Mizuki Tomihari; Akira Nishihara; Terumasa Shimada; Masashi Yanagawa; Masafumi Miyoshi; Kazurou Miyahara; Akihiro Oishi
Journal:  J Vet Med Sci       Date:  2015-05-11       Impact factor: 1.267

9.  Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer.

Authors:  Songtao Liu; Xinyu Gu; Lijiao Zhu; Guannan Wu; Hai Zhou; Yan Song; Congyou Wu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.